| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 200.49B | 196.69B | 174.34B | 162.69B | 138.41B | 110.44B |
| Gross Profit | 93.65B | 92.40B | 79.28B | 72.70B | 55.37B | 42.89B |
| EBITDA | 31.86B | 30.26B | 34.30B | 28.71B | 21.11B | 9.99B |
| Net Income | 19.46B | 18.69B | 21.70B | 17.83B | 12.28B | 3.75B |
Balance Sheet | ||||||
| Total Assets | 220.17B | 225.70B | 233.93B | 201.72B | 191.71B | 148.55B |
| Cash, Cash Equivalents and Short-Term Investments | 40.76B | 36.14B | 31.50B | 34.25B | 44.23B | 15.38B |
| Total Debt | 6.17B | 9.28B | 15.78B | 12.48B | 17.11B | 33.34B |
| Total Liabilities | 82.70B | 89.05B | 108.41B | 99.83B | 105.80B | 97.55B |
| Stockholders Equity | 137.47B | 136.65B | 125.51B | 101.89B | 85.90B | 51.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.14B | 12.06B | -2.68B | 21.44B | -3.29B |
| Operating Cash Flow | 0.00 | 23.10B | 15.30B | 3.35B | 22.60B | 3.36B |
| Investing Cash Flow | 0.00 | -855.00M | -18.03B | -5.73B | -648.00M | -6.99B |
| Financing Cash Flow | 0.00 | -17.12B | -798.00M | -8.73B | 5.52B | 3.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.07T | 30.90 | 12.80% | 0.78% | 7.09% | 7.51% | |
78 Outperform | ¥299.79B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
78 Outperform | ¥809.05B | 18.06 | 11.99% | 0.65% | 8.50% | 14.06% | |
75 Outperform | ¥1.14T | 19.48 | 11.14% | 1.46% | 3.92% | 9.99% | |
74 Outperform | ¥607.58B | 44.29 | 4.03% | 2.25% | 3.97% | -41.76% | |
62 Neutral | ¥458.56B | 19.19 | 5.63% | 2.35% | -9.06% | -35.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |